Palmoplantar Pustulosis Induced By Adalimumab: A Case Report

Authors

  • Abdullah Erman Yagiz Mustafa Kemal University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Hatay, Turkey
  • Nilgul Ustun Mustafa Kemal University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Hatay, Turkey
  • Ebru Celik Hatay Antakya State Hospital, Department of Dermatology, Hatay, Turkey.
  • Halil Ogut Mustafa Kemal University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Hatay, Turkey
  • Musa Demirkapi Mustafa Kemal University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Hatay, Turkey.
  • Mustafa Sahan Mustafa Kemal University, Faculty of Medicine, Department of Emergency Medicine, Hatay, Turkey.
  • Hayal Guler Mustafa Kemal University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Hatay, Turkey.
  • Ayse Dicle Turhanoglu Mustafa Kemal University, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Hatay, Turkey

Keywords:

Adalimumab, palmoplantar pustulosis

Abstract

TNF-α antagonists are used to treat a wide spectrum of moderate to severe inflammatory conditions such as ankylosing spondylitis (AS). During these treatments, cutaneous adverse effects may occur like psoriatic skin lesions. In this case report, we presented an unusual case of a 44 year old women with AS receiving adalimumab who developed an exacerbation of palmoplantar pustulosis. In conclusion, it should be kept in mind that psoriatic skin lesion may develop in patients receiving TNF-α antagonists and these findings may regress when the drug is withdrawn.

Downloads

Published

15-09-2013

How to Cite

Yagiz, A. E., Ustun, N., Celik, E., Ogut, H., Demirkapi, M., Sahan, M., … Turhanoglu, A. D. (2013). Palmoplantar Pustulosis Induced By Adalimumab: A Case Report. International Journal of Basic and Clinical Studies, 2(2), 135–139. Retrieved from https://www.ijbcs.com/ijbcs/article/view/ijbcs02220

Issue

Vol. 2 No. 2 (2013)

Section

Case Report

License

Copyright (c) 2013 By the Authors.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.